These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33655961)

  • 1. MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
    Chen L; Ke X
    Medicine (Baltimore); 2021 Mar; 100(9):e24953. PubMed ID: 33655961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
    Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
    Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on Integrated Gene Expression Profile Analysis.
    Luu Truong Thanh H; Hoang TM; Hoang Van H
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):885-892. PubMed ID: 38546071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete ablation of colon cancer cells may induce activation of dormant cells: Evidence from bioinformatics analysis.
    Lin W; Liu J; Lv W; Liu C; Sun Y; Zuo T
    J Cancer Res Ther; 2020; 16(7):1596-1602. PubMed ID: 33565505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma.
    Xu S; Liu D; Cui M; Zhang Y; Zhang Y; Guo S; Zhang H
    Biomed Res Int; 2022; 2022():1893351. PubMed ID: 35774271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
    Gao P; He M; Zhang C; Geng C
    Gene; 2018 May; 654():95-102. PubMed ID: 29408621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of key biomarkers and pathways in KSHV infected endothelial cells.
    Gong HB; Wu XJ; Pu XM; Kang XJ
    Medicine (Baltimore); 2019 Jul; 98(27):e16277. PubMed ID: 31277155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.